Methods |
Women randomly allocated to 2 groups. The method of randomisation not reported |
Participants |
456 women attending in an obs/gyn clinic, Boluo County Hospital, Guangdong, China. Women had regular menstrual periods, and a single act of unprotected intercourse within 72 h of attending the clinic |
Interventions |
Mife 25 mg, single dose, orally vs LNG 0.75 mg, 2 doses, 12 h apart, orally |
Outcomes |
Observed number of pregnancies, side effects and changes in menstrual pattern |
Notes |
Observed pregnancy/total number of women: Mife 2/250; LNG 2/206
-
Side effects:
Total side effects: Mife 32/250; LNG 30/206
-
Changes in menstrual pattern:
Early: Mife 14/248; LNG 20/204
Delay: Mife 40/248; LNG 22/204
Spotting: Mife 4/248; LNG 3/204
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
Mentioned randomisation but description not adequate |
Allocation concealment (selection bias) |
Unclear risk |
Method of allocation concealment not mentioned |
Blinding (performance bias and detection bias) All outcomes |
Unclear risk |
Not mentioned |
Incomplete outcome data (attrition bias) All outcomes |
Unclear risk |
No mention of post‐randomisation exclusion and loss to follow‐up |
Selective reporting (reporting bias) |
Low risk |
Planned outcome of pregnancy rate was reported |
Other bias |
Low risk |
None detected |